Evelyne Fournier1, Valérie Jooste2, Anne-Sophie Woronoff3, Valérie Quipourt4, Anne-Marie Bouvier2, Mariette Mercier5. 1. Doubs and Belfort Territory Cancer Registry, EA3181, University Hospital of Besancon, Besançon, France. Electronic address: efournier@chu-besancon.fr. 2. Burgundy Digestive Cancer Registry, Inserm U866, University of Burgundy, University Hospital of Dijon, Dijon, France. 3. Doubs and Belfort Territory Cancer Registry, EA3181, University Hospital of Besancon, Besançon, France. 4. Oncogeriatric Coordination Units, Geriatric Unit of Champmaillot, University Hospital of Dijon, Dijon, France. 5. University of Franche-Comté, EA3181, Molecular and Cellular Biology Laboratory, University Hospital of Besancon, Besançon, France; National Quality of Life in Oncology Platform, Besançon, France.
Abstract
BACKGROUND: Studies carried out in the context of clinical trials have shown a relationship between survival and health-related quality of life in colorectal cancer patients. AIMS: We assessed the prognostic value of health-related quality of life at diagnosis and of its longitudinal evolution on survival in older colorectal cancer patients. METHODS: All patients aged ≥65 years, diagnosed with new colorectal cancer between 2003 and 2005 and registered in the Digestive Cancer Registry of Burgundy were eligible. Patients were asked to complete the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 at inclusion, three, six and twelve months after. Multivariate regression models were used to evaluate the prognostic value of health-related quality of life scores at diagnosis and their deterioration on relative survival. RESULTS: In multivariate analysis, a role functioning dimension lower than median was predictive of lower survival (hazard ratio=3.1, p=0.015). After three and six months of follow-up, patients with greater appetite loss were more likely to die, with hazard ratios of 4.7 (p=0.013) and 3.7 (p=0.002), respectively. CONCLUSIONS: Health-related quality of life assessments at diagnosis are independently associated with older colorectal cancer patients' survival. Its preservation should be a major management goal for older cancer patients.
BACKGROUND: Studies carried out in the context of clinical trials have shown a relationship between survival and health-related quality of life in colorectal cancerpatients. AIMS: We assessed the prognostic value of health-related quality of life at diagnosis and of its longitudinal evolution on survival in older colorectal cancerpatients. METHODS: All patients aged ≥65 years, diagnosed with new colorectal cancer between 2003 and 2005 and registered in the Digestive Cancer Registry of Burgundy were eligible. Patients were asked to complete the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 at inclusion, three, six and twelve months after. Multivariate regression models were used to evaluate the prognostic value of health-related quality of life scores at diagnosis and their deterioration on relative survival. RESULTS: In multivariate analysis, a role functioning dimension lower than median was predictive of lower survival (hazard ratio=3.1, p=0.015). After three and six months of follow-up, patients with greater appetite loss were more likely to die, with hazard ratios of 4.7 (p=0.013) and 3.7 (p=0.002), respectively. CONCLUSIONS: Health-related quality of life assessments at diagnosis are independently associated with older colorectal cancerpatients' survival. Its preservation should be a major management goal for older cancerpatients.
Authors: Shane Lloyd; David Baraghoshi; Randa Tao; Ignacio Garrido-Laguna; Glynn W Gilcrease; Jonathan Whisenant; John R Weis; Courtney Scaife; Thomas B Pickron; Lyen C Huang; Marcus M Monroe; Sarah Abdelaziz; Alison M Fraser; Ken R Smith; Vikrant Deshmukh; Michael Newman; Kerry G Rowe; John Snyder; Niloy J Samadder; Mia Hashibe Journal: Am J Clin Oncol Date: 2019-04 Impact factor: 2.339
Authors: Biljana Gigic; Heiner Boeing; Reka Toth; Jürgen Böhm; Nina Habermann; Dominique Scherer; Petra Schrotz-King; Clare Abbenhardt-Martin; Stephanie Skender; Hermann Brenner; Jenny Chang-Claude; Michael Hoffmeister; Karen Syrjala; Paul B Jacobsen; Martin Schneider; Alexis Ulrich; Cornelia M Ulrich Journal: Nutr Cancer Date: 2017-12-15 Impact factor: 2.900
Authors: Miren Orive; Ane Anton-Ladislao; Santiago Lázaro; Nerea Gonzalez; Marisa Bare; Nerea Fernandez de Larrea; Maximino Redondo; Amaia Bilbao; Cristina Sarasqueta; Urko Aguirre; José M Quintana Journal: Support Care Cancer Date: 2022-06-23 Impact factor: 3.359